Home / Companies / Inflammatix Inc / Trends
Inflammatix Inc H-1B trends
Quarterly LCA aggregate trend points for Inflammatix Inc. Each point carries filing counts, distinct employers, distinct role titles, SOC coverage, wage metrics, certification counts, and source IDs when returned.
| Period | LCA count | Role titles | SOC codes | Avg wage low | Avg prevailing | Certified | Certification rate |
|---|---|---|---|---|---|---|---|
| 2019 Q2 | 1 | 1 | 1 | $111,259 | $111,259 | 1 | 100.0% |
| 2020 Q2 | 2 | 2 | 2 | $105,477 | $105,477 | 2 | 100.0% |
| 2020 Q4 | 2 | 2 | 2 | $103,855 | $103,855 | 2 | 100.0% |
| 2021 Q1 | 2 | 2 | 2 | $100,620 | $100,620 | 2 | 100.0% |
| 2021 Q2 | 2 | 2 | 2 | $100,620 | $100,620 | 2 | 100.0% |
| 2021 Q3 | 2 | 2 | 2 | $100,620 | $100,620 | 2 | 100.0% |
| 2021 Q4 | 2 | 2 | 2 | $90,012 | $90,012 | 2 | 100.0% |
| 2022 Q1 | 1 | 1 | 1 | $121,763 | $121,763 | 1 | 100.0% |
| 2022 Q2 | 2 | 1 | 1 | $127,878 | $127,878 | 2 | 100.0% |
| 2022 Q3 | 2 | 2 | 2 | $114,001 | $105,176 | 2 | 100.0% |
| 2022 Q4 | 2 | 2 | 2 | $127,311 | $108,909 | 2 | 100.0% |
| 2023 Q1 | 1 | 1 | 1 | $135,000 | $98,197 | 1 | 100.0% |
| 2023 Q2 | 4 | 3 | 3 | $120,684 | $106,803 | 4 | 100.0% |
| 2023 Q4 | 2 | 2 | 2 | $128,295 | $126,184 | 2 | 100.0% |
| 2024 Q1 | 2 | 2 | 2 | $88,307 | $78,947 | 2 | 100.0% |
| 2024 Q3 | 1 | 1 | 1 | $130,000 | $125,778 | 1 | 100.0% |
| 2024 Q4 | 2 | 2 | 1 | $174,096 | $166,400 | 2 | 100.0% |
| 2025 Q3 | 2 | 2 | 2 | $136,979 | $136,979 | 2 | 100.0% |
| 2026 Q2 | 1 | 1 | 1 | $138,133 | $138,133 | 1 | 100.0% |
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/trends?company=inflammatix+inc&metric=lca_countJSON